To support all the stakeholders involved in this exciting journey of biosimilars in the US, Samsung Bioepis will bring you this Samsung Bioepis Biosimilar Market Report.
The Samsung Bioepis Biosimilar Market Report will be published quarterly in conjunction with the release of the CMS ASP file. In the 1 st edition of the Samsung Bioepis Biosimilar Market Report, we provide an in-depth analysis of pricing and market share trends in the US market and for the following biosimilar categories: Oncology / Supportive Care / Immunology / Ophthalmology / Endocrinology
|